Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Vapotherm Stock: Can HVT 2.0 Lead to Gains?

Stock MarketsSep 20, 2021 02:00PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. Vapotherm Stock: Can HVT 2.0 Lead to Gains?

I am neutral on Vapotherm (NYSE:VAPO), as its attractive stock price and high potential pipeline make it look attractive. However, the company has a lot of risk stemming from its declining revenues and widening losses.

Vapotherm is a publicly held corporation that manufactures advanced respiratory technology for ventilator support.

The company is known for developing the first non-invasive, humidified high-velocity therapy nasal cannula system for patients suffering from respiratory distress, who cannot tolerate breathing masks.

Strengths

Vapotherm recently announced it has received 510(k) clearance from the FDA for its innovative next-generation system, the HVT 2.0. This particular system is designed to provide high flow therapy using an integrated air source.

The technology is expected to be released during the fourth quarter of 2021, and appears to be quite promising, since about 50% of hospital beds in the US do not have wall air. When used with a source of oxygen, HVT 2.0 will provide breathing support to patients in both hospitals and home settings.

Recent Results

Vapotherm reported revenue of $20.6 million for the second quarter of 2021, which shows a decrease of 41% year-over-year. Adjusted EBITDA was a loss of $12.3 million for the second quarter of 2021, compared to a loss of $4.3 million for the same quarter of the previous year. The loss was primarily due to lower COVID-related demand for equipment, leading to a reduction in revenue on a year-over-year basis.

The company also reported that it would expand its disposable equipment production capacity by increasing assembly lines in Mexico, resulting in a 75% increase in capacity. This will diversify Vapotherm’s manufacturing base, and is expected to improve the company’s gross margin in the coming months.

For Fiscal Year 2021, Vapotherm is now expecting revenue of $85 to $90 million, higher than the previously expected revenue, which was estimated to be between $82 million and $88 million.

Valuation Metrics

Vapotherm stock does not look too expensive when considering the EV/Revenue ratio of 7.1x. However, the company is not profitable, and is burning cash, which makes any valuation estimate quite speculative.

Furthermore, revenues are expected to decline in 2021 and 2022, while losses are also forecasted to widen. As a result, it is hard to make a clear case that the stock is undervalued at the moment.

Wall Street’s Take

From Wall Street analysts, Vapotherm earns a Strong Buy analyst consensus, based on three unanimous Buy ratings in the past three months. Additionally, the average VAPO price target of $40.67 puts the upside potential at 47%.

Summary and Conclusions

Vapotherm looks like an interesting speculative opportunity at the moment. On the one hand, the stock has decent upside potential. On the other hand, the stock is incredibly risky at the moment, burning cash at a rapid rate, and is not profitable yet.

In fact, its revenues are expected to decline slightly, and losses are expected to widen over the next year and a half.

Disclosure: On the date of publication, Samuel Smith had no position in any of the companies discussed in this article.

Disclaimer: The information contained in this article represents the views and opinion of the writer only, and not the views or opinion of TipRanks or its affiliates, and should be considered for informational purposes only. TipRanks makes no warranties about the completeness, accuracy or reliability of such information. Nothing in this article should be taken as a recommendation or solicitation to purchase or sell securities. Nothing in the article constitutes legal, professional, investment and/or financial advice and/or takes into account the specific needs and/or requirements of an individual, nor does any information in the article constitute a comprehensive or complete statement of the matters or subject discussed therein. TipRanks and its affiliates disclaim all liability or responsibility with respect to the content of the article, and any action taken upon the information in the article is at your own and sole risk. The link to this article does not constitute an endorsement or recommendation by TipRanks or its affiliates. Past performance is not indicative of future results, prices or performance.

Vapotherm Stock: Can HVT 2.0 Lead to Gains?
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email